A Pilot Observation and Feasibility Study of Prevora, Integrated Into Homecare Visits of High-risk Adults

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
COPD (Chronic Obstructive Pulmonary Disease)CHF (Congestive Heart Failure)DialysisChronic Metabolic Disorder
Interventions
DRUG

Prevora

"Prevora Stage 1, a topical, intra-oral solution of chlorhexidine acetate 100mg/ml followed immediately by Prevora Stage 2 which is a topical solution of polymethylmethacrylate. Prevora Stage 1 and Prevora Stage 2 are applied topically using a small brush and sequentially to the teeth and gum line of the patient/participant.~All subjects will receive at total 4 applications of Prevora 1 and 2. One on Day 1, 14 days, 3 months and 4 months."

Sponsors
All Listed Sponsors
collaborator

The Research Institute of St Joe's Hamilton

UNKNOWN

collaborator

St. Joseph's Health System - Centre for Integrated Comprehensive Care

UNKNOWN

lead

CHX Technologies Inc.

INDUSTRY

NCT06158633 - A Pilot Observation and Feasibility Study of Prevora, Integrated Into Homecare Visits of High-risk Adults | Biotech Hunter | Biotech Hunter